TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: frequency and severity of aggressive acts towards others
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: any effect on involuntary movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T. gondii infection status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean change in knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Postoperative pain strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With 1 or More Emergency Department Visits Per Quarter
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Posttraumatic Concern Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Posttraumatic Stress Disorder (PTSD) Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent reported number of hours screen time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of complications within the first 3 months after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Cleveland Clinic Incontinence Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Specific Airway Resistance (siRaw)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of completed anticipated directives
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of AD
Endpoint domain: Mortality/survival
Primary endpoint: Restoration of Normal Serum Potassium Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Serum Potassium Values ≤ 5.1 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adverse Events and Injection Site Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrent burst abdomen
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in physical activity measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-adjusted Area Under the Curve for FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Absolute CD4+ Lymphocyte Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Lowest Intraoperative Peripheral Oxygen Saturation (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awakening/Extubation Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fat fraction by vertebral level of the lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of caries incidence in DMF-T
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: cure rate of patients
Endpoint domain: Mortality/survival
Primary endpoint: Change in spacer volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IPSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elbow range of motion improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: biomarker change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression of Severity (CGI-S) Scores (Bipolar Population)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manchester Short Assessment of Quality of Life (MANSA) Scores (Schizophrenia Population) in Answer to: How Satisfied Are You With Your Mental Health?
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Young Mania Rating Scale (YMRS) Scores (Bipolar Population): Change From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyskinesia assessment scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Immunogenicity to dengue virus subtype one (DEN1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: oesophageal peristaltic contraction amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of mortality among enrolled COVID-19 patients
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of thrombosis among enrolled COVID patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in mean total hair density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accurate motility diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Completion of LDCT screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Connor Davidson Resilience Scale (CD-RISC)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical safety (including sepsis and death)
Endpoint domain: Adverse events/effects
Primary endpoint: Colonizing ability of L. plantarum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in stool microfloral patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular signs and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating MK counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to first diagnosis of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Extracellular volume fraction (ECV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in FLT uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Secretory IgA levels in mother's serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change in IBS symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative ultrasound data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain intensity in VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for analgesics in milligram
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: improvement in number of tender, swollen joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: DAS 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: NOAC level in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of CSF leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Median and three year survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Prediction of difficult laryngoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: time to perform procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: number of levels at which insertion is attempted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: number of ventral passes of the epidural needle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients treated as per studied guidelines
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Curve of Spee depth changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in gingival thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory Deficit (Cold Roller)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in average recovery time post dialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of paresthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Probability of severe (grade III/IV) GVHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in right ventricular ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: occlusion rate of aneurysm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in optic nerve sheath diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Use of pain medications after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Sirt6 expression in circulating leukocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of deceased participants at 1 month
Endpoint domain: Mortality/survival
Primary endpoint: Platelet Count Increase from < 80 Gi/L to >=100 Gi/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Platelet Counts Maintained at >=50 Gi/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Daily morphine milligram equivalents of opioid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total opioid consumption in morphine milligram equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant reported worst pain level on a numeric rating scale after surgery
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Overall benefit of anesthesia score (OBAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bladder Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Matsuda Index of Insulin Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Plasma Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Efficacy of working memory training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention Assessment (Stroop test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic Balance Assessment (Four-step Square Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Coordination Assessment (Lower extremity Motor Coordination Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal tolerated dose
Endpoint domain: Adverse events/effects
Primary endpoint: Change of Horovitz index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients with M + mutation status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Longitudinal clinical outcomes for patients with depression, post-traumatic stress disorder, and patient self-reported medication adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response (CR, CRi, PR) achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual perceptual performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Verbal cognitive performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Spatial cognitive performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Grade III-IV complications
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pain Score on Coughing at 6 hr
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct vs Incorrect Needle Placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perimetry changes over the years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brief Michigan Hand Questionnaire (brief MHQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Unite Rhumatologique des Affections de la Main (URAM) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily Pain and Function Scales
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Disease control rate at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal angle for internal jugular cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Tolerability during the first two vaccine courses
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of achieving good response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder Health Instrument
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Geometric Mean Human Serum Bactericidal Activity (hSBA) Titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentages of Subjects With hSBA Titer ≥1:5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Actuarial survival at six months
Endpoint domain: Mortality/survival
Primary endpoint: Total blood loss by the 3rd postoperative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: serum levels of Ca, P, PTH and vitamin D metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: lateral chest x-ray
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of GLPG1205 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful completion of dosage regimen with mild symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Color change according to CIE Lab system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum estradiol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Overall change in attitude towards the HPV vaccine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intent to have their child vaccinated against HPV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete resection rates (R0 resection rates)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Female sexual dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: median frequency of electromyogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of biomarkers for vasospasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge and attitude of dental students toward physical child abuse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma Glucagon response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma GLP-1 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma Glucose response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in diagnosis based on tcpO2 results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HbA1C from baseline to the end of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Pain Associated With Radiation-induced Mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venous Thromboembolic Events (VTE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Diagnosis Rate of Asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burn wound severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal reduction in granulation tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes from baseline VO2 peak (ml/kg/min) at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline resting heart rate (bpm) at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes from baseline Health-related quality of life at 12 weeks
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Global Appraisal of Individual Needs (GAIN) Substance Problem Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CGI-I mean score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to First Occurrence of Primary CV Event
Endpoint domain: Mortality/survival
Primary endpoint: Care and comport questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presence of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean Standardized Change in Synovial Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of Time That Valid CGM Glucose Readings Are Captured
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Time That Each Drug Channel of the iLet Bionic Pancreas is Available
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Ratio of Cumulative Drug Doses Delivered to Cumulative Drug Doses Attempted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enzyme intra-monocyte activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound Macrophage ROS production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NADPH oxidase expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Wound Fluid inflammatory cytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ranked Log10 HIV-1 RNA Viral Load (log10 Copies/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants Experiencing Either a CDC Category B or C Diagnosis, CD4<200 Cells/mm^3 or CD4 Percent <14%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: BIS variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in body weight of ≥2 kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of infections with bacteria resistant to antibiotics
Endpoint domain: Adverse events/effects
Primary endpoint: post-operative length of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: rate of same-day independent mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of CVD risk factors and diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Maximum Procedural Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall consumption of narcotics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: liver enzymes (SGOT and SGPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Mild Cognitive Impairment Progression to Alzheimer's Disease
Endpoint domain: Mortality/survival
Primary endpoint: Total grams of pretzels consumed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of post-operative urinary retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Diagnostic accuracy of trial of void parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Glycohemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diabetes nephropathy (macro-albuminuria and micro-albuminuria)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Peripheral arterial occlusive disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number Of Deaths
Endpoint domain: Mortality/survival
Primary endpoint: Number Of Participants Experiencing Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number Of Participants Achieving A Best Response Of Partial Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in self-reported swallowing function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: peak oxygen consumption (VO2peak; ml O2.kg-1.min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes